The Effect of Disease-Modifying Drugs on Brain Atrophy in Relapsing-Remitting Multiple Sclerosis: A Meta-Analysis

BACKGROUND: The quantification of brain atrophy in relapsing-remitting multiple sclerosis (RRMS) may serve as a marker of disease progression and treatment response. We compared the association between first-line (FL) or second-line (SL) disease-modifying drugs (DMDs) and brain volume changes over t...

Descripción completa

Detalles Bibliográficos
Autores principales: Branger, Pierre, Parienti, Jean-Jacques, Sormani, Maria Pia, Defer, Gilles
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4794160/
https://www.ncbi.nlm.nih.gov/pubmed/26983008
http://dx.doi.org/10.1371/journal.pone.0149685

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4794160/
https://www.ncbi.nlm.nih.gov/pubmed/26983008
http://dx.doi.org/10.1371/journal.pone.0149685

Ejemplares similares